Skip Nav Destination
Issues
1 July 2008
-
Cover Image
Cover Image
Expression of the BH3-only protein Bad in the cytoplasm of a primary human colon carcinoma. High Bad expression (shown) was detected in 97 (25.6%) cases, and low expression was found in 282 (74.4%). For further details, please see the article by Sinicrope and coworkers on page 4128 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Drug Updates
Molecular Pathways
Human Cancer Biology
Imaging, Diagnosis, Prognosis
Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening
Harri Sihto; Johan Lundin; Tiina Lehtimäki; Maarit Sarlomo-Rikala; Ralf Bützow; Kaija Holli; Liisa Sailas; Vesa Kataja; Mikael Lundin; Taina Turpeenniemi-Hujanen; Jorma Isola; Päivi Heikkilä; Heikki Joensuu
Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma
Francesca Diomedi-Camassei; Heather P. McDowell; Maria A. De Ioris; Stefania Uccini; Pierluigi Altavista; Giuseppe Raschellà; Roberta Vitali; Olga Mannarino; Luigi De Sio; Denis A. Cozzi; Alberto Donfrancesco; Alessandro Inserra; Francesco Callea; Carlo Dominici
Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma
Raffaella Villa; Maria Grazia Daidone; Rosita Motta; Lorenza Venturini; Cinzia De Marco; Alberto Vannelli; Shigeki Kusamura; Dario Baratti; Marcello Deraco; Aurora Costa; Roger R. Reddel; Nadia Zaffaroni
Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression
Talitha de Haas; Nancy Hasselt; Dirk Troost; Huib Caron; Mara Popovic; Lorna Zadravec-Zaletel; Wieslawa Grajkowska; Marta Perek; Maria-Chiara Osterheld; David Ellison; Frank Baas; Rogier Versteeg; Marcel Kool
Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis
Steven F. Moss; Jin-Woo Lee; Edmond Sabo; Anna K. Rubin; John Rommel; Bruce R. Westley; Felicity E.B. May; John Gao; Patricia A. Meitner; Rose Tavares; Murray B. Resnick
Cancer Therapy: Clinical
Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)
Pierpaolo Correale; Pierosandro Tagliaferri; Antonella Fioravanti; Maria Teresa Del Vecchio; Cinzia Remondo; Francesco Montagnani; Maria Saveria Rotundo; Chiara Ginanneschi; Ignazio Martellucci; Edoardo Francini; Maria Grazia Cusi; Pierfrancesco Tassone; Guido Francini
Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer
Yuichiro Ohe; Yukito Ichinose; Kazuhiko Nakagawa; Tomohide Tamura; Kaoru Kubota; Nobuyuki Yamamoto; Susumu Adachi; Yoshihiro Nambu; Toshio Fujimoto; Yutaka Nishiwaki; Nagahiro Saijo; Masahiro Fukuoka
Early Magnesium Reduction in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan as Predictive Factor of Efficacy and Outcome
Bruno Vincenzi; Daniele Santini; Sara Galluzzo; Antonio Russo; Fabio Fulfaro; Marianna Silletta; Fabrizio Battistoni; Laura Rocci; Bruno Beomonte Zobel; Vincenzo Adamo; Giordano Dicuonzo; Giuseppe Tonini
Cancer Therapy: Preclinical
The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated Killing
Mala Chakraborty; Elizabeth K. Wansley; Jorge A. Carrasquillo; Sarah Yu; Chang H. Paik; Kevin Camphausen; Michael D. Becker; William F. Goeckeler; Jeffrey Schlom; James W. Hodge
Attenuated Salmonella Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy
Frank Friedlos; Panos Lehouritis; Lesley Ogilvie; Douglas Hedley; Lawrence Davies; David Bermudes; Ivan King; Jan Martin; Richard Marais; Caroline J. Springer
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Jussi P. Koivunen; Craig Mermel; Kreshnik Zejnullahu; Carly Murphy; Eugene Lifshits; Alison J. Holmes; Hwan Geun Choi; Jhingook Kim; Derek Chiang; Roman Thomas; Jinseon Lee; William G. Richards; David J. Sugarbaker; Christopher Ducko; Neal Lindeman; J. Paul Marcoux; Jeffrey A. Engelman; Nathanael S. Gray; Charles Lee; Matthew Meyerson; Pasi A. Jänne
Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma
Priya Koppikar; Seung-Ho Choi; Ann Marie Egloff; Quan Cai; Shinsuke Suzuki; Maria Freilino; Hiroshi Nozawa; Sufi M. Thomas; William E. Gooding; Jill M. Siegfried; Jennifer R. Grandis
Dendritic Cell Vaccination with Xenogenic Polypeptide Hormone Induces Tumor Rejection in Neuroendocrine Cancer
Claudia Papewalis; Margret Wuttke; Jochen Seissler; Yvonne Meyer; Caroline Kessler; Benedikt Jacobs; Evelyn Ullrich; Holger S. Willenberg; Sven Schinner; Thomas Baehring; Werner A. Scherbaum; Matthias Schott
Vaccination with a Recombinant Saccharomyces cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses
Elizabeth K. Wansley; Mala Chakraborty; Kenneth W. Hance; Michael B. Bernstein; Amanda L. Boehm; Zhimin Guo; Deborah Quick; Alex Franzusoff; John W. Greiner; Jeffrey Schlom; James W. Hodge
Cancer Prevention and Susceptibility
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.